Schematic diagram of in vivo n3 VLC-PUFA biosynthetic pathway mediated by ELOVL4 and other ELO families [modified after Suh and Clandinin ()]
Schematic diagram of in vivo n3 VLC-PUFA biosynthetic pathway mediated by ELOVL4 and other ELO families [modified after Suh and Clandinin ()]. 18:3n3, 20:5n3, or 22:5n3 can be converted to VLC-PUFA through consecutive enzymatic activities of desaturases and elongases. Although some elongases are specific for a single step, others are nonspecific or multifunctional and act at several steps (e.g., human ELOVL5 and murine ELOVL2) (). We propose that ELOVL4 is essential for elongation of saturated 26:0 to 28:0 and of 26:5n3 to 28:5n3. It is also possible that ELOVL4 is necessary for generating (C30–C38):5n3 because these fatty acids are formed only in ELOVL4 expressing cells. However, other ELOVLs may be responsible for elongations of some of these VLC-PUFA (C30–C38) by using products generated by ELOVL4 elongase activity. The synthesis of 34:6n3 and 36:6n3 in our study suggests desaturase activity on their shorter chain precursors. However, the specific desaturase(s) involved is not known.
Publication
Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. (2008) Martin-Paul Agbaga, et al. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12843-12848. Figure: F4.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Mus musculus | Rodents | |ELOVL5,ELOVL2 | ELOVL5 | ncbigene_symbol | Elovl5 | 68801 |
| Mus musculus | Rodents | |ELOVL5,ELOVL2 | ELOVL2 | ncbigene_symbol | Elovl2 | 54326 |
| Mus musculus | Rodents | |ELOVL1/3 | ELOVL3 | ncbigene_symbol | Elovl3 | 12686 |
| Mus musculus | Rodents | |ELOVL1/3 | ELOVL1 | ncbigene_symbol | Elovl1 | 54325 |
| Mus musculus | Rodents | |ELOVL1/3 | EL3 | ncbigene_symbol | El3 | 111980 |
| Mus musculus | Rodents | ELOVL4 | ELOVL4 | ncbigene_symbol | Elovl4 | 83603 |
| Homo sapiens | Primates | |ELOVL5,ELOVL2 | ELOVL5 | ncbigene_symbol | ELOVL5 | 60481 |
| Homo sapiens | Primates | |ELOVL5,ELOVL2 | ELOVL2 | ncbigene_symbol | ELOVL2 | 54898 |
| Homo sapiens | Primates | |ELOVL1/3 | ELOVL3 | ncbigene_symbol | ELOVL3 | 83401 |
| Homo sapiens | Primates | |ELOVL1/3 | ELOVL1 | ncbigene_symbol | ELOVL1 | 64834 |
| Homo sapiens | Primates | |ELOVL1/3 | EL3 | ncbigene_synonym | SPTB | 6710 |
| Homo sapiens | Primates | ELOVL4 | ELOVL4 | ncbigene_symbol | ELOVL4 | 6785 |
| Rattus norvegicus | Rodents | |ELOVL5,ELOVL2 | ELOVL5 | ncbigene_symbol | Elovl5 | 171400 |
| Rattus norvegicus | Rodents | |ELOVL5,ELOVL2 | ELOVL2 | ncbigene_symbol | Elovl2 | 498728 |
| Rattus norvegicus | Rodents | |ELOVL1/3 | ELOVL3 | ncbigene_symbol | Elovl3 | 309449 |
| Rattus norvegicus | Rodents | |ELOVL1/3 | ELOVL1 | ncbigene_symbol | Elovl1 | 679532 |
| Rattus norvegicus | Rodents | ELOVL4 | ELOVL4 | ncbigene_symbol | Elovl4 | 315851 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|